phase readout
saveNCT07694115: Bioequivalence Study to Compare Empagliflozin/ Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg
COMPLETEDupdated 40m ago
community read0 votes
Sponsor: Humanis Saglık Anonim Sirketi. Phase: PHASE1. Conditions: Type 2 Diabetes Mellitus (T2DM)
view source ↗
comments(0)
5-min edit window · permanent after that